Gene knockdown of the N-methyl-d-aspartate receptor NR1 subunit with subcutaneous small interfering RNA reduces inflammation-induced nociception in rats

Anesthesiology

Volumn 112, Issue 6, 2010, Pages 1482-1493

  Tan, Ping Heng ^a   Chia, Yuan Yi ^b,c   Chow, Lok Hi ^c,d   Chen, Jieh Jie ^e   Yang, Lin Cheng ^a   Hung, Kuo Chuan ^a   Chen, Hung Shu ^a   Kuo, Chien Hung ^e  

^a I SHOU UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; SMALL INTERFERING RNA;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; INFLAMMATION; MALE; NOCICEPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PAIN; PRIORITY JOURNAL; RAT; RNA INTERFERENCE; SPINAL GANGLION;

EID: 77953025798     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181d69494     Document Type: Article

References (43)

1. Dickenson AH, Chapman V, Green G: The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol 1997; 28:633-638 (Pubitemid 27244410)
2. Dickenson AH, Sullivan AF: Evidence for a role of the NMDA receptor in frequency dependent potentiation of deep rat dorsal horn nociceptive neurons following C fibre stimulation. Neuropharmacology 1987; 26:1235-1238
3. Long SK, Smith DAS, Siarey RJ, Evans RH: Effect of 6-cyano-2,3,- dihydroxy-7-nitro-quinoxaline (CNQX) on dorsal root-, NMDA-, kainate-, and quisqualate-mediated depolarization of rat motoneurones in vitro. Br J Pharmacol 1990; 100: 850-854
4. Woolf CJ, Costigan M: Transcriptional and post transla-tional plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A 1999; 96:7723-7730
5. Watkins JC, Evans RH: Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 1981; 21:165-204
6. Carlton SM, Hargett GL, Coggeshall RE: Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci Lett 1995; 197:25-28
7. Davidson EM, Coggeshall RE, Carlton SM: Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. NeuroRe-port 1997; 8:941-946
8. Stein C, Millan MJ, Herz A: Unilateral inflammation of the hind paw in rats as a model of prolonged noxious stimulation: Alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 1988; 31:445-451
9. Leem JW, Hwang JH, Hwang SJ, Park H, Kim MK, Choi Y: The role of peripheral N-methyl-D-aspartate receptors in Freund's complete adjuvant induced mechanical hyperal-gesia in rats. Neurosci Lett 2001; 297:155-158
10. Cull-Candy S, Brickley S, Farrant M: NMDA receptor sub-units: Diversity, development, and disease. Curr Opin Neu-robiol 2001; 11:327-335
11. Carlton SM, Coggeshall RE: Inflammation-induced changes in peripheral glutamate receptor population. Brain Res 1999; 820:63-70
12. Du J, Zhou S, Coggeshall RE, Carlton SM: N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience 2003; 118:547-562
13. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391:806-811 (Pubitemid 28099681)
14. Elbashir SM, Lendeckel W, Tuschl T: RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001; 15:188-200 (Pubitemid 32107664)
15. Dorn G, Patel S, Wotherspoon G, Hemmings-Mieszczak M, Barclay J, Natt FJ, Martin P, Bevan S, Fox A, Ganju P, Wishart W, Hall J: siRNA relieves chronic neuropathic pain. Nucleic Acids Res 2004; 32:e49
16. Kawasaki Y, Xu Z-Z, Wang XY, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, Ji RR: Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008; 14:331-336
17. Luo MC, Zhang DQ, Ma SW, Huang YY, Shuster SJ, Porreca F, Lai J: An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. Mol Pain 2005; 28:1-29
18. Tan PH, Yang LC, Shih HC, Lan KC, Cheng JT: Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther 2005; 12:59-66
19. Zimmermann M: Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-110
20. Boyce S, Wyatt A, Webb JK, O'Donnell R, Mason G, Rigby M, Sirinathsinghji D, Hill RG, Rupniak NM: Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: Correlation with restricted localization of NR2B subunit in dorsal horn. Neuropharmacology 1999; 38:611-623
21. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Meth 1994; 53:55-63
22. Dixon WJ: Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980; 20:441-462
23. Yukhananov R, Guan J, Crosby G: Antisense oligonucleo-tide to N-methyl-D-aspartate receptor subunits attenuate formalin-induced nociception in the rat. Brain Res 2002; 930:163-169
24. Mao J: NMDA and opioid receptors: Their interactions in antinociception, tolerance and neuroplasticity. Brain Res Brain Res Rev 1999; 30:289-304
25. Price DD, Mayer DJ, Mao J, Caruso FS: NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J Pain Symptom Manage 2000; 19(1 suppl):S7-11
26. South SM, Kohno T, Kaspar BK, Hegarty D, Vissel B, Drake CT, Ohata M, Jenab S, Sailer AW, Malkmus S, Masuyama T, Horner P, Bogulavsky J, Gage FH, Yaksh TL, Woolf CJ, Heinemann SF, Inturrisi CE: A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. J Neurosci 2003; 23:5031-5040
27. Enarson MC, Hays H, Woodroffe MA: Clinical experience with oral ketamine. J Pain Symptom Manage 1999; 17: 384-386
28. Rabben T, Skjelbred P, Oye I: Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther 1999; 289:1060-1066
29. Schmid RL, Sandler AN, Katz J: Use and efficacy of low-dose ketamine in the management of acute postoperative pain: A review of current techniques and outcomes. Pain 1999; 82:111-125
30. Carlton SM: Peripheral excitatory amino acids. Curr Opin Pharmarcol 2001; 1:52-56
31. Lau CG, Zukin RS: NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007; 8:413-426
32. Thakor D, Spigelman I, Tabata Y, Nishimura I: Subcutaneous peripheral injection of cationized gelatin/DNA poly-plexes as a platform for non-viral gene transfer to sensory neurons. Mol Ther 2007; 15:2124-2131
33. Zhou S, Bonasera L, Carlton SM: Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. NeuroReport 1996; 7:895-900
34. Coderre TJ, Melzack R: The contribution of excitatory amino acids to central sensitization and persistent noci-ception after formalin-induced tissue injury. J Neurosci 1992; 12:3665-3670
35. McCall WD, Tanner KD, Levine JD: Formalin induces bi-phasic activity in C-fibers in the rat. Neurosci Lett 1996; 208:45-48
36. Meller ST, Dykstra C, Gebhart GF: Production of endogenous nitric oxide and activation of soluble guanylate cy-clase are required for N-methyl-D-aspartate produced facilitation of the nociceptive tail-flick reflex. Eur J Pharmacol 1992; 214:93-96
37. Bursztajn S, Rutkowski MD, Deleo JA: The role of the N-methyl-D-aspartate receptor NR1 subunit in peripheral nerve injury-induced mechanical allodynia, glial activation and chemokine expression in the mouse. Neuroscience 2004; 125:269-275
38. Kim TW, Lee JH, He L, Boyd DA, Hardwick JM, Hung CF, Wu TC: Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency. Cancer Res 2005; 65:309-316
39. Peer D, Zhu P, Carman CV, Lieberman J, Shimaoka M: Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc Natl Acad Sci USA 2007; 104:4095-4100
40. Glorioso JC, Mata M, Fink DJ: Exploiting the neurothera-peutic potential of peptides: Targeted delivery using HSV vectors. Expert Opin Biol Ther 2003; 3:1233-1239
41. Katada A, Vos JD, Swelstad BB, Zealear DL: A sequential double labeling technique for studying changes in mo-toneuronal projections to muscle following nerve injury and reinnervation. J Neurosci Methods 2006; 155:20-27
42. Puigdellivol-Sanchez A, Valero-Cabre A, Prats-Galino A, Navarro X, Molander C: On the use of fast blue, fluoro-gold and diamidino yellow for retrograde tracing after peripheral nerve injury: Uptake, fading, dye interactions, and toxicity. J Neurosci Methods 2002; 115:115-127
43. Wang S, Ma N, Gao SJ, Yu H, Leong KW: Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes. Mol Ther 2001; 3:658-664